Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Rhea-AI Summary

Cosmos Health (NASDAQ:COSM) expanded its digital assets program by purchasing $500,000 of Bitcoin, bringing total cryptocurrency investments to $2.5 million. Ethereum remains a key pillar while the company will selectively evaluate other cryptocurrencies based on market conditions and strategic fit.

The purchase was executed at an average price below $70,000 per Bitcoin, reflecting a disciplined, opportunistic capital deployment approach aligned with long-term financial objectives.

News Market Reaction

-2.18%

1 alert

-2.18% News Effect

On the day this news was published, COSM declined 2.18%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Bitcoin purchase: $500,000 Total crypto investments: $2.5 million BTC purchase level: Below $70,000 per Bitcoin +5 more

8 metrics

Bitcoin purchase $500,000 New BTC investment under digital assets program

Total crypto investments $2.5 million Combined Ethereum and Bitcoin holdings to date

BTC purchase level Below $70,000 per Bitcoin Average execution price cited for latest BTC buy

Shelf registration $200,000,000 Maximum amount on replacement Form S-3 shelf

ATM program size $100,000,000 At-the-market common stock offering capacity via A.G.P.

Shares outstanding 34,919,920 Common shares outstanding as of Nov 6, 2025

Non-affiliate float 26,274,546 shares Common shares held by non-affiliates Nov 6, 2025

Last close (Nov 6, 2025) $0.67 COSM Nasdaq closing price referenced in S-3

Market Reality Check

Price: $0.3732 Vol: Volume 552,302 vs 20-day ...

low vol

$0.3732 Last Close

Volume Volume 552,302 vs 20-day average 1,362,353, indicating lighter-than-usual trading ahead of this news. low

Technical Shares at $0.4246, trading below the $0.65 200-day moving average and 67.84% under the 52-week high.

Peers on Argus

COSM was down 0.92% pre-news while only one tracked peer (EDAP) appeared in mome...

1 Up

COSM was down 0.92% pre-news while only one tracked peer (EDAP) appeared in momentum scans, up 4.78% without related news, suggesting stock-specific rather than sector-driven dynamics around this crypto treasury update.

Previous Crypto Reports

5 past events · Latest: Jan 20 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 20	Operations update	Positive	-5.6%	Detailed Cosmofarm growth, higher revenue per customer, and robotics expansion.
Jan 14	Analyst coverage	Positive	-4.7%	Zacks Small-Cap Research initiated coverage with a $4.50 per-share valuation.
Jan 05	Manufacturing deal	Positive	+3.0%	Cana Labs signed PathMuscle manufacturing agreement with minimum volume commitments.
Dec 24	Strategy update	Positive	+1.1%	Q3 revenues above $17M and U.S. manufacturing strategy to reduce tariff exposure.
Dec 19	Record quarter	Positive	-4.0%	Record revenue north of $17M and disclosure of a $500,000 Ethereum purchase.

Pattern Detected

Recent tagged ‘crypto/strategy’ and growth updates have often seen mixed-to-negative next-day moves despite generally positive operational or strategic content.

Recent Company History

Over the last few months, Cosmos Health issued several crypto/strategy-tagged updates, including operational growth at Cosmofarm (Jan 20, 2026), initiation of analyst coverage with a $4.50 valuation (Jan 14, 2026), and a manufacturing agreement for PathMuscle with volumes expected above 1.2 million units. Earlier, the company highlighted platform-building efforts and record quarterly revenue above $17 million, alongside Ethereum purchases. This Bitcoin-focused expansion fits into that ongoing strategy of using digital assets within a broader capital deployment framework.

Historical Comparison

crypto

-2.0 %

Average Historical Move

Historical Analysis

In the past 5 tagged ‘crypto/strategy’ updates, COSM’s average next-day move was -2%, showing markets have often reacted cautiously to similar announcements.

Typical Pattern

Crypto-related communications evolved from initial ETH treasury use and financing capacity disclosures toward broader platform, growth, and now Bitcoin-inclusive digital asset deployment.

Regulatory & Risk Context

Active S-3 Shelf · $200,000,000

Shelf Active

Active S-3 Shelf Registration 2025-11-07

$200,000,000 registered capacity

An effective Form S-3 shelf filed on Nov 7, 2025 registers up to $200,000,000 of securities, including an at-the-market program of up to $100,000,000 in common stock. The company stated that net proceeds are intended primarily for acquisition of crypto assets as a treasury asset and for general corporate purposes and working capital.

Market Pulse Summary

This announcement extends Cosmos Health’s digital asset strategy from Ethereum toward a more diversi...

Analysis

This announcement extends Cosmos Health’s digital asset strategy from Ethereum toward a more diversified crypto treasury, adding a $500,000 Bitcoin purchase and bringing total investments to $2.5 million. Historically, similar ‘crypto/strategy’ updates saw an average -2% next-day move, signaling cautious market reception. The existing $200,000,000 shelf and $100,000,000 ATM, with proceeds earmarked partly for crypto assets, remain key elements for assessing future capital deployment and dilution risk.

Key Terms

bitcoin, ethereum, cryptocurrencies, tokenization

4 terms

bitcoin technical

"purchase of $500,000 of Bitcoin (BTC), underscoring the Company’s"

Bitcoin is a decentralized digital currency and asset that exists only online, created and recorded through a public digital record maintained by many computers worldwide—think of it as a shared spreadsheet that no single person controls. Investors care because it behaves like a high-risk, high-reward store of value and speculative commodity: its supply is limited, its price can swing sharply, and owning it can change a portfolio’s risk, diversification and exposure to market sentiment.

ethereum technical

"digital assets program has so far been centered on Ethereum (ETH). While"

Ethereum is a digital money system and computing platform built on a shared online ledger called a blockchain; its native token, ether (ETH), is used to pay for transactions and run automated contracts. Investors care because ether acts like a tradeable asset whose price can move sharply, and the platform’s usage, upgrades, and rules affect supply, demand and potential returns—think of it as both a new kind of commodity and the fuel for a global app store.

cryptocurrencies technical

"inclusion of additional cryptocurrencies within this framework, based on market"

Cryptocurrencies are digital forms of money or tokens secured by cryptography and recorded on shared digital ledgers, like a public spreadsheet that many computers maintain together. They matter to investors because their market values can swing widely, can act as speculative investments or portfolio diversifiers, and are exposed to unique risks such as regulatory changes, cybersecurity threats, and adoption shifts that can quickly affect prices.

tokenization technical

"including, as previously disclosed, exploring potential opportunities related to the tokenization of high-value"

Tokenization is the process of converting real-world assets or rights into digital tokens stored on a computer network. This allows assets, such as property or investments, to be divided into smaller parts, making them easier to buy, sell, or transfer electronically. For investors, tokenization can increase access to a wider range of investments and make transactions faster and more efficient.

AI-generated analysis. Not financial advice.

CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the expansion of its digital assets program with the purchase of $500,000 of Bitcoin (BTC), underscoring the Company’s disciplined, opportunistic, and flexible approach to capital deployment.

The Company’s digital assets program has so far been centered on Ethereum (ETH). While Ethereum will continue to serve as a key pillar of the program, the addition of Bitcoin represents a strategic evolution intended to broaden exposure across established digital assets.

Cosmos Health is also selectively evaluating the inclusion of additional cryptocurrencies within this framework, based on market conditions and alignment with the Company’s broader financial strategy. This expanded approach enhances the Company’s flexibility to respond to changing market dynamics, supports diversification, and enables the pursuit of opportunities consistent with its long-term financial objectives and shareholder interests, including, as previously disclosed, exploring potential opportunities related to the tokenization of high-value intellectual property.

To date, Cosmos Health has invested a total of $2.5 million in cryptocurrencies, reflecting the combined value of its Ethereum holdings and the newly completed Bitcoin investment.

Greg Siokas, CEO of Cosmos Health, stated: "Our digital assets strategy is designed to be adaptive, disciplined, and opportunistic. The decision to invest in Bitcoin, executed at an average price below $70,000 per Bitcoin, reflects our view that deploying capital during periods of intense market sell-offs can create value over time. While Ethereum remains a key pillar of our digital assets program, we believe that adding Bitcoin, along with the potential inclusion of other select cryptocurrencies, enhances diversification and strengthens our overall capital deployment strategy.”

About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.

Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.

Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com

FAQ

What did Cosmos Health (COSM) announce about its Bitcoin purchase on February 11, 2026?

Cosmos Health purchased $500,000 of Bitcoin, raising total crypto investments to $2.5 million. According to the company, the buy averaged below $70,000 per BTC and broadens its Ethereum-centered digital assets program for diversification.

How does the $500,000 Bitcoin purchase affect Cosmos Health's (COSM) digital assets strategy?

The purchase broadens the program beyond Ethereum and increases diversification within the crypto allocation. According to the company, this change adds flexibility to respond to market dynamics while pursuing long-term financial objectives and potential tokenization opportunities.

Will Cosmos Health (COSM) add other cryptocurrencies to its portfolio after the Bitcoin investment?

The company is selectively evaluating additional cryptocurrencies and has not committed to specific assets. According to the company, inclusion will depend on market conditions and alignment with its broader financial strategy and shareholder interests.

At what price did Cosmos Health (COSM) buy Bitcoin and why did it choose that timing?

Cosmos Health bought Bitcoin at an average price below $70,000 per BTC. According to the company, the timing reflects a disciplined, opportunistic approach to deploy capital during market sell-offs to potentially create long-term value.

How large are Cosmos Health's (COSM) total cryptocurrency holdings after the latest purchase?

Total cryptocurrency holdings are now $2.5 million combining prior Ethereum investments and the new Bitcoin purchase. According to the company, this represents the company’s current digital assets exposure under its expanded program.